Orion's revenues rise by 9% on pharma growth
This article was originally published in Scrip
Executive Summary
Orion, the Finnish pharmaceutical and diagnostics company, ended 2009 strongly with a full-year revenue increase of almost 9% to €772 million and double-digit growth of its operating profit.